X0306 4/A 2019-07-29 2019-07-31 0 0001566044 Menlo Therapeutics Inc. MNLO 0001266163 BALL KRISTINE M 200 CARDINAL WAY, 2ND FLOOR REDWOOD CITY CA 94063 0 1 0 0 See Remarks Restricted Stock Units 2019-07-29 4 A 0 80300 0.00 A Common Stock 80300 413423 D Each Restricted Stock Unit ("RSU") represents a contingent right to receive a share of the Issuer's common stock. The RSUs shall vest in two (2) equal annual installments beginning July 29, 2020, provided Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissable Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest. Not Applicable SVP Corporate Strategy and Chief Financial Officer The Form 4 filed on 7/31/2019 provided an incorrect title of the reporting person, did not identify the signatory as signing as attorney-in-fact for the reporting person and failed to include the relevant power of attorney of the reporting person as an exhibit thereto. This Form 4/A amendment is filed to correct the aforementioned errors. Except as otherwise noted in this Form 4/A, all other information disclosed in the Reporting Person's original Form 4 filed with the Securities and Exchange Commission on 7/31/2019 was accurately reported. /s/ Ronald A. Krasnow as attorney-in-fact for Kristine Ball 2019-08-07